Harvard doctors and public health experts recommend using the website PharmacyChecker.com to find international online pharmacies to order more affordable prescription drugs for personal importation when domestic savings strategies fail. They offer this advice in a new article in the Journal of the American Medical Association. Article Review The article, Strategies to Help Patients Navigate High Prescription Drug […]
Author: Gabriel Levitt
Founder of Prescription Justice, the Prescription Justice Institute, and an advisor to PharmacyChecker.
Oregon Federal Court Says PharmacyChecker—Which Helps Americans Find Vetted International Online Pharmacies—Is Legal
Last week, in Oregon’s Federal District Court, Judge Michael H. Simon denied summary judgment to the defendant, LegitScript, an online verification company, thwarting its effort to escape a lawsuit brought by PharmacyChecker. The antitrust lawsuit alleges that LegitScript illegally conspired with numerous Big Pharma-allied groups to blacklist PharmacyChecker on the Internet. LegitScript argued that PharmacyChecker […]
Economic Theory Explains Big Pharma Scare Tactics on Importation
New economic theory shows that, due to personal drug importation, U.S. drug prices are connected with drug prices in other countries.
Statements and Thoughts on Motion on Summary Judgment in PharmacyChecker v. NABP et al.
[This post relates to a case titled PharmacyChecker.com v. the National Association of Boards of Pharmacy et al., in which PharmacyChecker alleges an unlawful “conspiracy involving front groups for Big Pharma” that keep “lower priced drugs out of reach of millions of Americans.” Just recently, a federal judge in New York’s southern district granted the defendants summary judgment. This […]
Senator Burr: Rip Van Winkle Performance on Drug Importation, Owes Italy an Apology
This past June, during a debate in the Senate Health, Education, Labor and Pensions (HELP) Committee, Senator Richard Burr (R-NC), the committee’s Ranking Member, demonstrated that he does not understand very important developments in our nation’s approach to drug regulation and safety. It was almost as if Sen. Burr had fallen asleep over 20 years ago and woke […]
DOJ Investigates $250 Million in U.S. Sales of Counterfeit Drugs Using Fake DSCSA Pedigrees
The U.S. Department of Justice, according to Seeking Alpha, is investigating the sale and distribution of counterfeit drugs in the U.S. that may have amounted to a quarter-billion dollars. The investigation comes about two months after The Wall Street Journal reported on a lawsuit filed by Gilead Sciences alleging a massive breach in the U.S. drug supply chain […]
Manitoba Judge’s Opinion Reveals Different Side of the CanadaDrugs Case
A recent opinion from an appeals court in Manitoba, Canada sheds new and more favorable light about the CanadaDrugs-related wholesale drug importation case that was first covered a decade ago in the Wall Street Journal. The case pertained to an indictment of CanadaDrugs, Ltd. for sales of mostly misbranded (but not counterfeit drugs) and two […]
Mark Cuban’s Pharmacy Dreams Are Generic
Mark Cuban’s new online pharmacy venture – the Mark Cuban Cost Plus Drug Company (“Cost Plus Drug”) – will not help overcome the biggest obstacle to drug affordability in America, which is drug company monopolies on patented brand name prescription drugs. When only one company makes a drug and can charge as much as the […]
State Boards of Pharmacy Missing in Action During Opioid Crisis
This post should serve as the beginning of a serious inquiry into the failure of U.S. state boards of pharmacy to properly regulate pharmacies that irresponsibly and too often illegally profited from opioid drug sales to patients. Sociologist Elizabeth Chiarello writes, “Boards have a duty to protect the public, but because they are mostly comprised […]
The Domain Reform for Unlawful Drug Sellers Act is Big Pharma’s Bill
UPDATE: Senator Amy Klobuchar (D-MN) has withdrawn her sponsorship and support for this bill. A new bill introduced by Sens. Mark Rubio (R-FL) and Amy Klobuchar (D-MN), called the “Domain Reform for Unlawful Drug Sellers Act’’ or, for short, the ‘‘DRUGS Act,’’ could effectively end online access to safe and affordable imported medicines for Americans. […]